Tuberculosis remains a critical public health issue in many countries and is a leading cause of death in South Africa. Over the past six years, the BEAT Tuberculosis study, conducted in South Africa and focused on children and pregnant women, has revealed a promising new oral treatment that could mark a significant breakthrough in the fight against drug-resistant TB. Zaheer Cassim reports.
Denial of responsibility! Pioneer Newz is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.
